Trevena Inc (NYSE: TRVN) — Healthcare · Share Price, Chart & Market Data
About: Trevena, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel medicines for patients affected by central nervous system disorders. Its lead product candidates include OLINVYK (Oliceridine) injection, a G protein biased mu-opioid receptor (MOR) ligand for the management of moderate-to-severe acute pain; TRV734, a small molecule G protein biased ligand of the MOR, which has completed phase I studies for the treatment of moderate-to-severe acute and chronic pain; and TRV045, a novel S1P modulator for managing chronic pain. Trevena, Inc. was incorporated in 2007 and is headquartered in Chesterbrook, Pennsylvania.
Sector: Healthcare
Industry: Biotechnology
Latest price: $0.01 (-45.00%)
TRVNTrevena Inc
Loading watchlist status…
Trade TRVN now
Trevena Inc share price
TRVN price activity
Last Price
Change (24hr)
USD (%)
Volume
Volume (4w avg)
Previous Close
N/A
Last Trade
Delayed
27 Apr, 1:44 pm GMT+0
TRVN price performance
0%
5D
-45%
1M
-8.333%
YTD
-99.079%
1Y
TRVN price fundamentals
N/A
Shares Issued
N/A
Dividends Per Share (DPS)
N/A
Earnings Per Share (EPS)
N/A
P/E Ratio
Price market cap
Market cap
N/A
NYSE rank
N/A
Sector Rank
N/A
Delayed
27 Apr, 1:44 pm GMT+0
TRVN details
TRVN Market Signals